easysite
You are here > Services > Research and Development > Our current areas of Research > Cancer Studies > General Oncology Cancer Studies
.

General Oncology Cancer Studies

Add-Aspirin

A phase III, double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.

Study Area: General Oncology

Aim: To assess whether regular aspirin use after standard therapy (surgery, chemotherapy, radiotherapy or combinations thereof) prevents recurrence and prolongs survival in participants with non-metastatic common solid tumours.

Who can participate: Men and women aged over 16 who have recently had curative treatment for Breast, Prostate, Colorectal, Oesophageal or Gastric Cancer and who are able to take a daily dose of Aspirin for up to 5 years.


CAVA: Cancer and Venous Access

Study Area: General Oncology

Aim: A trial comparing two different types of central lines needed for an intended chemotherapy regime. Randomisation to receive either a PICC (peripherally inserted central catheter) or a portacath before or during chemotherapy. Lines are monitored for infections or any problems, as well as how they affect your daily life. After the PICC or port being put in you will be asked to complete a short questionnaire once a month or so whenever you attend for your chemotherapy appointment.

Who can participate: Anyone who is due to commence chemotherapy and has been advised that they will need a central line.

If you would like any further information on the following studies, and to find out if you are eligible please contact:

 

Address: R&D office, C254, West Wing, Broomfield Hospital, Court Road, Chelmsford, Essex, CM1 7ET

Telephone: 01245 515136
Email: Research@meht.nhs.uk